Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Serine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 402Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/10/2025 Evonik
    Germany
    		 EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CN R1-CEP 2014-366 - Rev 01 Serine, Wuming site 2023-08-24 Valid Chemical 788
    31/10/2025 Evonik
    Germany
    		 EVONIK REXIM S.A.S. Ham FR R1-CEP 2007-020 - Rev 01 Serine, Bio-enzymatic synthesis process 2014-03-21 Withdrawn by Holder Chemical 2025-05-19 788